Mathias Kranz

9PUBLICATIONS
23CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersCharacterisation of biological macromoleculesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 20, 2026
CXCR4-targeted PET imaging of glioblastoma using [68Ga]Ga-TD-01: from pharmacokinetics and dosimetry to theranostic potential.

|Aug 20, 2024
Radiosynthesis and preclinical evaluation of a 68Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma.

Piyapan Suwattananuruk, Sukanya Yaset, Chanisa Chotipanich

|Nov 23, 2022
Glioblastoma PET/MRI: kinetic investigation of [18F]rhPSMA-7.3, [18F]FET and [18F]fluciclovine in an orthotopic mouse model of cancer.

Marcel Lindemann, Ana Oteiza, Montserrat Martin-Armas

|Mar 06, 2021
Development of 18F-Labeled Radiotracers for PET Imaging of the Adenosine A2A Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation.

Thu Hang Lai, Susann Schröder, Magali Toussaint

|Feb 10, 2021
Preclinical Evaluation of [18F]FACH in Healthy Mice and Piglets: An 18F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET.

Daniel Gündel, Masoud Sadeghzadeh, Winnie Deuther-Conrad

|Jan 28, 2021
Synthesis and Biological Evaluation of a Novel 18F-Labeled Radiotracer for PET Imaging of the Adenosine A2A Receptor.

Thu Hang Lai, Magali Toussaint, Rodrigo Teodoro

Pageof 2

Frequent Collaborators

6 joint publications

Peter Brust

5 joint publications

Winnie Deuther-Conrad

4 joint publications

Rareş-Petru Moldovan

3 joint publications

Magali Toussaint